Pharmacy Wields Antitrust Law In Challenge To GLP-1 Giants
By Lauren Berg · January 14, 2026, 9:49 PM EST
Eli Lilly & Co. and Novo Nordisk are using their dominant positions in the market for weight loss and diabetes medications to squash potential competitors, including through unlawful exclusivity agreements with...
To view the full article, register now.